Mild Cognitive Impairment and Alzheimer's Disease: First Do No Harm



Date & Location
Friday, September 23, 2022, 8:00 AM - Wednesday, June 25, 2025, 11:59 PM

Target Audience
Specialties - Allergy/Immunology, Anesthesiology, Bariatric Surgery, Cardiac Electrophysiology, Cardiac Surgery, Cardiovascular Disease, Colon and Rectal Surgery, Critical Care Medicine, Dermatology, Emergency Medicine, Endocrinology, Diabetes and Metabolism, Family Medicine, Gastroenterology, Geriatric Medicine, Gynecologic Oncology, Gynecology, Hematology, Hepatobiliary, Hepatology, Hospice and Palliative Medicine, Infectious Disease, Internal Medicine, Interventional Cardiology, Interventional Radiology, Medical Genetics and Genomics, Medical Oncology, Neonatology, Nephrology, Neurology, Neurosurgery, Nuclear Medicine, Obstetrics, Oncology, Ophthalmology, Orthopaedic Surgery, Orthopaedics, Other, Otolaryngology, Pain Medicine, Palliative Medicine, Pathology, Pediatric Gastroenterology, Pediatrics, Physical Medicine/ Rehabilitation, Plastic Surgery, Podiatric Surgery, Podiatry, Preventive Medicine, Psychiatry, Psychology , Pulmonology, Radiation Oncology, Radiology, Rheumatology, Sports Medicine, Surgery, Thoracic Surgery, Transplant, Urogynecology, Urology, Vascular Surgery
Professions - Non-Physician, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Psychologist, Social Worker

Overview

This activity will cover topics related to dementia, including Alzheimer’s Disease and cognitive decline. The audience will learn about the differences between normal age-related cognitive changes and signs of neurological disease. This module will cover the history of dementia treatments, currently available treatment options, and how to best care for dementia patients.


Objectives
After completing this activity, the participant will be able to:

  1. Evaluate the harms and benefits of current pharmacological treatment and prevention options for Alzheimer’s Disease and Mild Cognitive Impairment (MCI).
  2. Discuss non-pharmacological approaches to preventing cognitive decline.
  3. Integrate a team-based approach in the care of normally aging patients, patients with MCI, and patients with dementia, including Alzheimer’s Disease
  4. Integrate a team-based approach in the care of patients with Alzheimer’s Disease and Mild Cognitive Impairment (MCI).

Accreditation

In support of improving patient care, this activity has been planned and implemented by MedStar Health. MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credits
AMA PRA Category 1 Credits™ Physician (1.00 hours), ASWB Social Worker: Clinical (1.00 hours), IPCE (1.00 hours), Non-Physician Member of the Healthcare Team (1.00 hours), Nurse - ANCC (1.00 hours), Pharmacist - ACPE (1.00 hours), Psychologist-APA (1.00 hours)